Depomed reported $61.39M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aerie Pharmaceuticals AERI:US $ 56.44M 19.25M
Ani Pharmaceuticals ANIP:US $ 76.91M 23.39M
Aurora Cannabis Inc ACB:CN 429.89M 97.49M
Cara Therapeutics CARA:US $ 21.36M 7.91M
Daiichi Sankyo 4568:JP Y 662477M 85182M
Depomed DEPO:US $ 61.39M 24.58M
Ironwood Pharmaceuticals IRWD:US $ 593.37M 26.76M
Johnson & Johnson JNJ:US $ 1579M 322M
Knight Therapeutics Inc GUD:CN C$ 4.61M 4.42M
Merk MRK:US $ 8556M 460M
Nektar Therapeutics NKTR:US $ 67.99M 42.78M
Omeros OMER:US $ 8.96M 91.84M
Pfizer PFE:US $ 2470M 526M
Teva Pharmaceutical TEVA:IT 2.18B 10M